GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PEPTONIC medical AB (XSAT:PMED) » Definitions » EBITDA Margin %

PEPTONIC medical AB (XSAT:PMED) EBITDA Margin % : -81.63% (As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is PEPTONIC medical AB EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. PEPTONIC medical AB's EBITDA for the three months ended in Mar. 2024 was kr-8.82 Mil. PEPTONIC medical AB's Revenue for the three months ended in Mar. 2024 was kr10.81 Mil. Therefore, PEPTONIC medical AB's EBITDA margin for the quarter that ended in Mar. 2024 was -81.63%.


PEPTONIC medical AB EBITDA Margin % Historical Data

The historical data trend for PEPTONIC medical AB's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PEPTONIC medical AB EBITDA Margin % Chart

PEPTONIC medical AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -476.88 -130.47 -147.14 -63.72 -91.60

PEPTONIC medical AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -61.96 -54.41 -68.92 -227.56 -81.63

Competitive Comparison of PEPTONIC medical AB's EBITDA Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, PEPTONIC medical AB's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PEPTONIC medical AB's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PEPTONIC medical AB's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where PEPTONIC medical AB's EBITDA Margin % falls into.



PEPTONIC medical AB EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

PEPTONIC medical AB's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-34/37.118
=-91.60 %

PEPTONIC medical AB's EBITDA Margin % for the quarter that ended in Mar. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=-8.823/10.808
=-81.63 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PEPTONIC medical AB  (XSAT:PMED) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


PEPTONIC medical AB EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of PEPTONIC medical AB's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


PEPTONIC medical AB (XSAT:PMED) Business Description

Traded in Other Exchanges
Address
Gustavslundsvägen 143, Bromma, SWE, SE-167 51
PEPTONIC medical AB is a pharmaceutical company. It is engaged in developing oxytocin-based products for the treatment of menopausal symptoms, such as vaginal atrophy and vaginal dryness. Oxytocin is for medical use and offers an alternative to estrogen and estrogen-like acting compounds for menopausal and postmenopausal women. The company is based in Sweden.

PEPTONIC medical AB (XSAT:PMED) Headlines

No Headlines